Loading
Latest filing published 18 Mar 2022 for Axcella Health Inc., €68k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Our data holds just one disclosure by Robert Crane, dated 18 March 2022, reporting an open-market purchase worth €68k in Axcella Health Inc. Further filings will be added here. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration